Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

NIH initiates interstitial cystitis trial

Aug. 16, 1999

Phase II testing of Alexion's C5 complement inhibitor also begins in renal diseases

Aug. 12, 1999

FDA puts hold on clinical study of Vasomax

Aug. 12, 1999

BioSpecifics Technologies announces positive preliminary results in Peyronie's disease therapy

Aug. 11, 1999

Mochida presents potent and selective heterocyclic cGMP-PDE inhibitors

July 30, 1999

NS-49: preclinical pharmacokinetics of potential new agent for stress incontinence

July 28, 1999

Rochester Medical's female incontinence device receives CE mark

July 28, 1999

Nitrosylated alpha-adrenoceptor antagonists as potential agents for impotence

July 27, 1999

Alza expands promotion of Ditropan XL for overactive bladder

July 27, 1999

Z-350, a novel treatment for BPH with a dual mechanism of action

July 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...